WEST PHARMACEUTICAL SERVICES, INC. Revenues
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Revenues of $695.40 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-25.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2024-04-25
- WEST PHARMACEUTICAL SERVICES, INC. revenues for the quarter ending 2024-03-31 was $695.40M, a 2.96% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for the quarter ending 2023-03-31 was $716.60M, a 0.47% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for the quarter ending 2022-03-31 was $720.00M, a 7.35% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for the quarter ending 2021-03-31 was $670.70M, a 36.46% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for fiscal 2022 was $2.89B, a 1.95% increase from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for fiscal 2021 was $2.83B, a 31.89% increase from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for fiscal 2020 was $2.15B, a 16.69% increase from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. revenues for fiscal 2019 was $1.84B, a 7.13% increase from fiscal 2018.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2024-03-31 | $695.40M 10-Q · filed 2024-04-25 | |||
| 2023-03-31 | $716.60M 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | $2.89B 10-K · filed 2023-02-21 | |||
| 2022-03-31 | $720.00M 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $2.83B 10-K · filed 2023-02-21 | |||
| 2021-03-31 | $670.70M 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | $2.15B 10-K · filed 2023-02-21 | |||
| 2020-03-31 | $491.50M 10-Q · filed 2021-04-30 | $962.10M derived: sum of 2 quarters · filed 2022-02-22 | $1.42B derived: sum of 3 quarters · filed 2022-02-22 | $1.89B derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $470.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $926.70M derived: sum of 2 quarters · filed 2022-02-22 | $1.40B derived: sum of 3 quarters · filed 2022-02-22 | $1.84B 10-K · filed 2022-02-22 |
| 2019-09-30 | $456.10M 10-Q · filed 2019-10-29 | $925.80M derived: sum of 2 quarters · filed 2019-10-29 | $1.37B 10-Q · filed 2019-10-29 | $1.79B derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $469.70M 10-Q · filed 2019-07-29 | $913.20M 10-Q · filed 2019-07-29 | $1.34B derived: sum of 3 quarters · filed 2021-02-23 | $1.77B derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $443.50M 10-Q · filed 2020-04-24 | $866.00M derived: sum of 2 quarters · filed 2021-02-23 | $1.30B derived: sum of 3 quarters · filed 2021-02-23 | $1.75B derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $422.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $854.20M derived: sum of 2 quarters · filed 2021-02-23 | $1.30B derived: sum of 3 quarters · filed 2021-02-23 | $1.72B 10-K · filed 2021-02-23 |
| 2018-09-30 | $431.70M 10-Q · filed 2019-10-29 | $879.20M derived: sum of 2 quarters · filed 2019-10-29 | $1.29B 10-Q · filed 2019-10-29 | $1.71B derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $447.50M 10-Q · filed 2019-07-29 | $863.20M 10-Q · filed 2019-07-29 | $1.28B derived: sum of 3 quarters · filed 2020-02-24 | $1.68B derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $415.70M 10-Q · filed 2019-05-08 | $831.30M derived: sum of 2 quarters · filed 2020-02-24 | $1.23B derived: sum of 3 quarters · filed 2020-02-24 | |
| 2017-12-31 | $415.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $813.80M derived: sum of 2 quarters · filed 2020-02-24 | $1.60B 10-K · filed 2020-02-24 | |
| 2017-09-30 | $398.20M 10-Q · filed 2018-10-30 | $1.18B 10-Q · filed 2018-10-30 | ||
| 2016-12-31 | $1.51B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |